Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 01/04/2015 6:49:48 PM
Post# of 30066
Posted By: Trojan09
"To improve the diagnostic process, a wide variety of techniques and specimen types have been the subject of investigation, including brain imaging techniques and analysis of cerebrospinal fluid (Frank et al., 2003), but the associated costs and procedural risk limit their widespread use. In contrast, venous puncture is a widely accepted low risk, low cost specimen collection procedure. Therefore, a blood-based test for AD diagnosis would be favorable, provided such a test complies with conditions for an “ideal” AD biomarker as outlined in the Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer's Disease” (Consensus Report of the Working Group, 1998). In that regard, the collection and analysis of peripheral blood lymphocytes could potentially fulfill this unmet clinical need."

Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site